Volume V, Issue 40

Oct. 1, 2018
DEA Reschedules Epidiolex, Paving the Way to Market
Megan Brooks reports for Medscape on 9.27.18:

The U.S. Drug Enforcement Administration (DEA) has rescheduled the epilepsy cannabidiol (CBD) drug Epidiolex ( GW Pharmaceuticals) from Schedule I to Schedule V, the classification with the lowest degree of restriction - paving the way to market for the cannabis-based treatment, the company has announced. As reported by Medscape Medical News, the U.S. Food and Drug Administration (FDA) approved the drug in June for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS) or Dravet syndrome in patients aged 2 years and older. The approval followed a unanimous thumbs up by an FDA advisory committee in April.

"We are pleased that the DEA has placed Epidiolex in the lowest restriction Schedule, because it will help ensure that patients with LGS and Dravet syndrome, two of the most debilitating forms of epilepsy, can access this important new treatment option through their physicians," Justin Gover, GW's CEO, said in a news release.
Log in/complimentary registration required.
Spotlight on Big Food 
Martha Rosenberg launches a blistering attack on Big Food in a 9.27.18 KevinMD post. She notes that food industry giants like Nestle are targeting second world nations with heavy junk food marketing tactics. She highlights Big Food's questionable ties to nutrition research, the American Heart Association, the American Academy of Pediatrics and other prominent institutions. Ms. Rosenberg also discusses the huge political contributions that are used to sway health policy in the U.S. and in other nations.

The spotlight has shown quite brightly lately on a dysfunctional health system, greedy pharmaceutical companies and inept insurance companies. Far too little focus has been placed on Big Food. Our grandmother taught us that "we are what we eat." Meanwhile, "food is medicine" has become cliche. Despite this we often overlook the elephant in the room. It's no secret that cardiovascular disease, hypertension and metabolic disorder are among the top chronic conditions in the U.S. today ( CDC.gov). The Western diet of carbohydrate rich, processed foods combined with sedentary lifestyles are major drivers of these diseases.
Despite Disappointing Debut, EHR Is the Way Forward in Healthcare  
Evan Sweeney reports for Fierce Healthcare on 9.26.18:
In an ideal world, clinicians would have virtually no interaction with a patient's EHR. Instead, doctors and nurses would spend the majority of their time with patients and EHR data would be populated with "little or no effort." Vital signs would be instantly uploaded by an automated assistant, artificial intelligence would offer personalized treatment options and relevant data would flow seamlessly through the rest of the system. That's the vision of EHRs in the year 2028 as described in a new report from Stanford Medicine based on input from industry experts that attended a June symposium hosted by the medical school. 
EHRs may soon serve as the backbone of an information revolution in healthcare, one that will transform healthcare the way digital technologies are changing banking, finance, transportation, navigation, internet search, retail and other industries, the report states.
Read More



About Us
Florida Health Industry Week in Review is published every Monday by

Each Monday morning, we share the top healthcare headlines of the previous week and summarize
What Happened (WH) and
Why It Matters (WIM).

To learn how you can join our team of editorial contributors, contact Jeffrey Herschler .

Inside FloridaHealthIndustry.com

Inform  Connect  Engag e
FHI logo cropped small version